SOMAÍ Pharmaceuticals
A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint
About SOMAÍ Pharmaceuticals
SOMAÍ Pharmaceuticals is a leading EU-GMP European pharmaceutical and biotech company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceuticals portfolio. At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine. SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of the few vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
Company Facts
- Headquarters
- Dublin
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Funding Stage
- late_stage_venture
- Total Funding
- $42,219,680
- Last Funding Type
- series_c
- Last Funding Date
- 2025-05-01
- Website
- somaipharma.eu
Industries & Categories
Biopharma, Biotechnology, Cannabis, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/soma-pharmaceuticals-57357 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.